Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Evolus Inc (NASDAQ: EOLS) was $5.91 for the day, down -2.31% from the previous closing price of $6.05. In other words, the price has decreased by -$2.31 from its previous closing price. On the day, 1.3 million shares were traded. EOLS stock price reached its highest trading level at $6.128 during the session, while it also had its lowest trading level at $5.8125.
Ratios:
Our analysis of EOLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 2.02.
On April 17, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $21.
Barclays Upgraded its Equal Weight to Overweight on January 29, 2024, whereas the target price for the stock was revised from $10 to $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 22 ’25 when MOATAZEDI DAVID sold 10,539 shares for $7.15 per share. The transaction valued at 75,361 led to the insider holds 354,388 shares of the business.
Avelar Rui sold 2,261 shares of EOLS for $16,168 on Dec 22 ’25. The insider now owns 356,821 shares after completing the transaction at $7.15 per share. On Aug 22 ’25, another insider, Yamagishi-Dressler Tomoko, who serves as the Chief Marketing Officer of the company, sold 5,722 shares for $7.51 each. As a result, the insider received 42,972 and left with 89,949 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 383084928 and an Enterprise Value of 494453920. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.34. Its current Enterprise Value per Revenue stands at 1.73 whereas that against EBITDA is -15.731.
Stock Price History:
The Beta on a monthly basis for EOLS is 1.12, which has changed by -0.4074437 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, EOLS has reached a high of $17.12, while it has fallen to a 52-week low of $5.71. The 50-Day Moving Average of the stock is -13.94%, while the 200-Day Moving Average is calculated to be -29.34%.
Shares Statistics:
EOLS traded an average of 1.24M shares per day over the past three months and 939540 shares per day over the past ten days. A total of 64.77M shares are outstanding, with a floating share count of 49.66M. Insiders hold about 23.39% of the company’s shares, while institutions hold 79.98% stake in the company. Shares short for EOLS as of 1765756800 were 6346498 with a Short Ratio of 5.11, compared to 1763078400 on 11279632. Therefore, it implies a Short% of Shares Outstanding of 6346498 and a Short% of Float of 10.0.
Earnings Estimates
. The current market rating for Evolus Inc (EOLS) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.08, with high estimates of $0.01 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.16 and -$0.47 for the fiscal current year, implying an average EPS of -$0.39. EPS for the following year is $0.13, with 5.0 analysts recommending between $0.35 and $0.01.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 6 analysts. It ranges from a high estimate of $93.7M to a low estimate of $88.5M. As of. The current estimate, Evolus Inc’s year-ago sales were $78.95MFor the next quarter, 6 analysts are estimating revenue of $76.6M. There is a high estimate of $82.7M for the next quarter, whereas the lowest estimate is $70.5M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $300.5M, while the lowest revenue estimate was $295.4M, resulting in an average revenue estimate of $297.47M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $351.66M in the next fiscal year. The high estimate is $364.39M and the low estimate is $339.1M.
